Recent Updates
Recently added Catalysts
BLFS Positive Sentiment

BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025

Monday, November 17, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: BioLife Solutions, Inc. announced its participation in upcoming investor conferences in November and December 2025. The company is a prominent developer of bioproduction products for the cell and gene therapy market. Their investor presentation, featuring a refreshed corporate branding, is available on their website, highlighting their commitment to investor engagement.
Price reaction · baseline $24.07 (2025-11-14 close) · hit pre-market · 1 other BLFS headline(s) in the window, move may be shared
day 0 close
-0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • BioLife Solutions is actively engaging with investors.
  • The company is showcasing its refreshed corporate branding.
  • Participation in multiple investor conferences indicates growth potential.

Full Press Release Details

BOTHELL, Wash.,Nov. 17, 2025/PRNewswire/ --BioLife Solutions, Inc.(NASDAQ:BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) market, today announced that management will participate in the following investor conferences during November and December:
The BioLife SolutionsInvestor Presentation, reflecting the recently refreshed corporate branding, is now available on theInvestor Relationssection of the company's website.

About BioLife Solutions

BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visitwww.biolifesolutions.comor follow BioLife onLinkedInandX.

Media & Investor Relations

Frequently Asked Questions

When will BioLife Solutions participate in investor conferences?

BioLife Solutions will participate in investor conferences during November and December 2025.

What is the focus of BioLife Solutions?

BioLife Solutions specializes in bioproduction products for the cell and gene therapy market.

Where can I find the investor presentation?

The investor presentation is available on the Investor Relations section of BioLife's website.

What does BioLife Solutions provide?

BioLife Solutions provides solutions that maintain the health of biologic materials during various stages.

ShareAdd on Google
Tags: BLFS Viatris Investor Conferences Healthcare BioLife Solutions investor conferences cell and gene therapy bioproduction products
Last updated: Nov 17, 2025

Biotech snapshot

Cash runway
$81M liquidity · $0M/mo burn
~491 mo
Low dilution risk